February 03, 2016
An Illinois federal judge on Tuesday dismissed a proposed class action accusing GNC and the makers of a now-defunct anti-inflammatory drug of fraudulently misleading consumers into believing it could help their arthritis pain, saying the claims weren't specific enough but could be amended.